Evocalcet
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12388 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hyperphosphatemia (disease) | KG + DL |
| 2 | tumoral calcinosis, hyperphosphatemic, familial | KG + DL |
| 3 | familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome | KG + DL |
| 4 | pancreatitis | KG + DL |
| 5 | hereditary hypercarotenemia and vitamin A deficiency | KG + DL |
| 6 | primary hyperoxaluria | KG + DL |
| 7 | familial apolipoprotein C-II deficiency | KG + DL |
| 8 | C1 inhibitor deficiency | KG + DL |
| 9 | familial isolated deficiency of vitamin E | KG + DL |
| 10 | disorder of vitamin and non-protein cofactor absorption and transport | KG + DL |
| 11 | lipase deficiency, combined | KG + DL |
| 12 | primary immunodeficiency syndrome due to p14 deficiency | KG + DL |
| 13 | serpinopathy with toxic serpin polymerization | KG + DL |
| 14 | autosomal recessive severe congenital neutropenia due to G6PC3 deficiency | KG + DL |
| 15 | cerebellar ataxia-ectodermal dysplasia syndrome | KG + DL |
| 16 | major hypertriglyceridemia | KG + DL |
| 17 | corneal-cerebellar syndrome | KG + DL |
| 18 | ataxia - deafness - intellectual disability syndrome | KG + DL |
| 19 | Lichtenstein-Knorr syndrome | KG + DL |
| 20 | constitutional megaloblastic anemia due to vitamin B12 metabolism disorder | KG + DL |
| 21 | familial isolated hypoparathyroidism due to agenesis of parathyroid gland | KG + DL |
| 22 | Barth syndrome | KG + DL |
| 23 | esophageal varices with bleeding | KG + DL |
| 24 | esophageal varices without bleeding | KG + DL |
| 25 | severe congenital neutropenia | KG + DL |
| 26 | X-linked cerebellar ataxia | KG + DL |
| 27 | myoclonic cerebellar dyssynergia | KG + DL |
| 28 | cyclic hematopoiesis | KG + DL |
| 29 | autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome due to TUD deficiency | KG + DL |
| 30 | leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome | KG + DL |
| 31 | autosomal recessive ataxia due to ubiquinone deficiency | KG + DL |
| 32 | biotinidase deficiency | KG + DL |
| 33 | autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | KG + DL |
| 34 | autosomal recessive cerebellar ataxia-blindness-deafness syndrome | KG + DL |
| 35 | autosomal recessive cerebellar ataxia-saccadic intrusion syndrome | KG + DL |
| 36 | hereditary angioedema with C1Inh deficiency | KG + DL |
| 37 | Charlevoix-Saguenay spastic ataxia | KG + DL |
| 38 | autosomal recessive ataxia, Beauce type | KG + DL |
| 39 | autosomal recessive severe congenital neutropenia due to CXCR2 deficiency | KG + DL |
| 40 | alcoholic cardiomyopathy | KG + DL |
| 41 | varicose disease | KG + DL |
| 42 | early-onset cerebellar ataxia with retained tendon reflexes | KG + DL |
| 43 | parathyroid hyperplasia (disease) | KG + DL |
| 44 | autosomal recessive severe congenital neutropenia due to CSF3R deficiency | KG + DL |
| 45 | symptomatic form of hemophilia in female carriers | KG + DL |
| 46 | immune-mediated necrotizing myopathy | KG + DL |
| 47 | congenital neutropenia-myelofibrosis-nephromegaly syndrome | KG + DL |
| 48 | familial lipoprotein lipase deficiency | KG + DL |
| 49 | X-linked severe congenital neutropenia | KG + DL |
| 50 | antisynthetase syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.